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Abstract
Background: Metallo-β-lactamases are bacterial enzymes that provide resistance to carbapenems, the most potent
class of antibiotics. These enzymes are commonly encoded on mobile genetic elements, which, together with their
broad substrate spectrum and lack of clinically useful inhibitors, make them a particularly problematic class of antibiotic
resistance determinants. We hypothesized that there is a large and unexplored reservoir of unknown metallo-β-
lactamases, some of which may spread to pathogens, thereby threatening public health. The aim of this study
was to identify novel metallo-β-lactamases of class B1, the most clinically important subclass of these enzymes.
Results: Based on a new computational method using an optimized hidden Markov model, we analyzed over 10,000
bacterial genomes and plasmids together with more than 5 terabases of metagenomic data to identify novel metallo-
β-lactamase genes. In total, 76 novel genes were predicted, forming 59 previously undescribed metallo-β-lactamase
gene families. The ability to hydrolyze imipenem in an Escherichia coli host was experimentally confirmed for 18 of the
21 tested genes. Two of the novel B1 metallo-β-lactamase genes contained atypical zinc-binding motifs in their active
sites, which were previously undescribed for metallo-β-lactamases. Phylogenetic analysis showed that B1 metallo-β-
lactamases could be divided into five major groups based on their evolutionary origin. Our results also show that,
except for one, all of the previously characterized mobile B1 β-lactamases are likely to have originated from
chromosomal genes present in Shewanella spp. and other Proteobacterial species.
Conclusions: This study more than doubles the number of known B1 metallo-β-lactamases. The findings have further
elucidated the diversity and evolutionary history of this important class of antibiotic resistance genes and prepare us
for some of the challenges that may be faced in clinics in the future.
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Background
Carbapenems are broad-spectrum β-lactams that are
often used when treating life-threatening infections or as
a last resort for infections caused by multidrug resistant
bacteria [1, 2]. Resistance to carbapenems is mediated by
carbapenemases, which are β-lactamases that hydrolyze
the β-lactam ring of carbapenem antibiotics [3]. Carba-
penemases are present in three of the four molecular
classes of β-lactamases, and while carbapenemases in
classes A and D use a catalytic serine for hydrolysis, the
class B enzymes (metallo-β-lactamases), which all are
carbapenemases, are dependent on zinc ions for their
activity [4]. Metallo-β-lactamases have broad-spectrum
activity profiles, and the majority of these enzymes
are able to hydrolyze penicillins and cephalosporins in
addition to carbapenems. Furthermore, there are no
clinically available inhibitors that can block the
metallo-β-lactamase activity, which makes the class B
metallo-β-lactamases a particularly worrisome class of
resistance genes [5].
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Metallo-β-lactamases can be phylogenetically divided
into three subclasses, B1, B2, and B3 [6]. Metallo-β-
lactamases from subclass B1 (B1BL) and subclass B3 use
two zinc ions within their active sites and have a much
broader resistance spectrum compared to subclass B2,
which uses only one zinc ion [3]. Furthermore, the vast
majority of the mobile class B carbapenemases identified
to date belong to subclass B1, including the clinically
important IMP (for “active on imipenem”) and VIM
(Verona integron-encoded metallo-β-lactamase) gene
families that are commonly found in integrons, transpo-
sons, and plasmids [7, 8]. The more recently identified
B1BL gene family NDM (New Dehli metallo-β-
lactamase), first discovered in 2009 on a plasmid in a
Klebsiella pneumoniae strain [9], has spread globally in
the span of only a few years and today is found in
multidrug-resistant bacteria in many countries [10],
underscoring the increasing clinical importance of
surveillance of carbapenemases from the B1 subclass.
Environmental and commensal bacterial communities
are known to maintain a large diversity of clinically
relevant antibiotic resistance genes [11, 12]. This diver-
sity is known to be especially large in environments with
an antibiotic selection pressure, such as environments
polluted with antibiotics from the production of phar-
maceuticals and wastewater treatment plants [13–15]. In
addition to the already known resistance genes, bacterial
communities also harbor a wide range of novel resist-
ance determinants that have yet to be encountered in
clinical settings [16–18]. If mobilized, these genes may
be transferred to pathogens, either directly or indirectly
via commensal bacteria in humans or animals, which can
lead to infections that are difficult or impossible to treat
[2]. Indeed, previously uncharacterized β-lactamases,
including class B carbapenemases, have been found in
bacterial communities sampled from Alaskan, apple
orchard, and agricultural soils and cow manure [19–22]. It
is therefore likely that current knowledge regarding B1BLs
only reflects “the tip of the iceberg” and that the full diver-
sity of these enzymes is far from being completely de-
scribed. This is further emphasized by the fact that many
original hosts of the currently known mobile B1BL genes
have not yet been identified, making their evolutionary or-
igins unclear. Further examination of environmental and
commensal bacteria in search of potentially new B1BLs is
therefore important and would enable the identification
and surveillance of potent genes before they are mobilized
and horizontally transferred into pathogens. Expanding
the number of known chromosomal and mobile B1BL
genes would also provide a more detailed phylogenetic
view of this gene class and facilitate the further elucidation
of their origin and evolutionary history [23].
The amount of genomic data present in public reposi-
tories has rapidly accumulated in recent years and for
bacteria alone, the amount of data deposited in GenBank
has shown a yearly increase of approximately 50% [24].
The same is true for metagenomic data available in
public repositories, which has grown in size due to re-
cent breakthroughs in high-throughput DNA sequencing
[25]. In contrast to sequencing of individual strains,
metagenomics enables the characterization of entire
communities, including the large proportion of bacteria
that are hard to cultivate under normal laboratory con-
ditions [26]. However, the fragmented nature of metage-
nomic data makes it a non-trivial task to search for
novel genes. This is especially true for B1BL genes, for
which the sequence similarity between gene families can
be as low as 28% [27]. Thus, a large proportion of the
sequence data in the public repositories has not been
analyzed for novel B1BLs, despite the fact these data are
likely to contain a large number of previously unde-
scribed gene variants.
In this study, we aim to substantially extend our know-
ledge of B1BLs by searching for previously undescribed
genes in available bacterial DNA sequence data. To en-
able the analysis of sequences from both isolated strains
as well as fragmented metagenomic data, we developed
a sensitive computational method that can identify
conserved evolutionary patterns from genes within the
B1BL subclass using a hidden Markov model (HMM).
Cross-validation was used to optimize the parameters of
the model to identify previously undescribed B1BL genes
with high accuracy. The method was then used to search
bacterial genomes and plasmids present in the NCBI
GenBank RefSeq database as well as more than five tera-
bases of metagenomic data from human and environ-
mental bacterial communities. In total, we identified 76
novel B1BL genes that could be divided into 59 novel
gene families. Twenty-one of the genes were selected for
experimental validation, 86% (18 of 21) of which were
confirmed to yield imipenem-hydrolyzing activity when
expressed in an Escherichia coli host. Two of the novel
genes were located within a genetic context that suggests
they may be mobile. Phylogenetic analysis of the com-
bined set of previously described and novel metallo-β-
lactamases showed that the B1BLs can be organized into
five distinct groups that are largely defined by the
taxonomy of their hosts. The results of this study sub-
stantially increase the number of identified B1BLs, some
of which may pose a threat to public health in the future
and provides a more detailed picture of their diversity
and evolutionary history.
Results
In this study, we applied a computational method to
predict novel B1BLs in genomes and metagenomes. The
method was designed based on a sensitive hidden
Markov model (HMM) created from previously known
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B1BL genes with verified activity against carbapenems
(see “Methods” section, Additional file 1: Figure S1). The
method is applicable to both genomes and metagen-
omes, and the output consists of predicted full-length
B1BL genes. Cross-validation was used to optimize the
true positive rate to identify previously undescribed
B1BL genes. For full-length genes, the method correctly
classified all tested B1BL genes (an estimated true
positive rate of 100%), while the false positive rate (FPR)
was very low, even for closely related genes from the
MBL superfamily [23] (an FPR of 0% for all tested gene
groups within the MBL superfamily). For metagenomic
data, using a fragment length of 100 nucleotides, the
method showed a true positive rate of 89% and a FPR of
4% and 0% for the MBL superfamily and random gen-
omic fragments, respectively.
The method was used to search for novel B1BL genes
in bacterial genomes, plasmids, and other bacterial DNA
sequences present in the NCBI GenBank repository.
From sequences that were present in NCBI RefSeq
bacteria, consisting of 2744 complete genomes and 162
draft genomes, 92 B1BL genes were predicted (Table 1).
In total, 88 genomes (3.2%) and 2 plasmids carried one
B1BL gene, and one genome carried two B1BL genes
(Shewanella denitrificans strain OS217). The occurrence
of B1BL genes was significantly higher in Gram-negative
bacteria (5.3%) compared to Gram-positive bacteria
(1.7%) (p = 0.0022, Fisher’s exact test). In addition, there
was a strong overrepresentation of B1BL-carrying bac-
teria in the phylum Bacteroidetes (22.4%) compared to
bacteria from other phyla (3.0%) (p = 1.17 × 10−9,
Fisher’s exact test). When Bacteroidetes was excluded
from the Gram-negative set, there was still a tendency
towards an overrepresentation of B1BL-carrying Gram-
negative bacteria (p = 0.0713, Fisher’s exact test). We
found, however, no association between the distribution
of B1BL genes and human-associated bacteria or
pathogens as defined by the PATRIC database [28]
(p = 0.8695 and p = 0.6021, respectively).
Among the predicted B1BL genes in RefSeq bacteria,
one was located on the chromosome of Pseudomonas
stutzeri DSM 10701. This gene was found to be most
closely related to the previously identified mobile B1BL
gene KHM-1 (54% amino acid sequence identity). Inter-
estingly, this gene was located on a genomic insert that
was present in only one out of six P. stutzeri genomes
available in NCBI GenBank. In addition to the B1BL
gene, the insert also contained a gene encoding the pro-
tein domain NERD, associated with endonucleases previ-
ously found on virulence plasmids [29], as well as genes
belonging to the Fic/DOC domain family (pfam02661),
previously connected with a toxin-antitoxin module
from the E. coli prophage P1 [30].
Among the NCBI RefSeq plasmids, consisting of 9225
sequences, we predicted 148 B1BL genes, of which 147
were associated with previously known gene families
(Table 1). One identified gene, located on a plasmid
from Myroides odoratimimus strain PR63039, had a
sequence identity lower than 70% to any previously
described B1BL. This plasmid also harbored the gene
tet(X), which confers resistance to tetracycline and
tigecycline, another last-resort broad-spectrum antibiotic
[31, 32] and genes associated with class B type IV secre-
tion systems (TraMB) [33]. The analysis of the NT and
EnvNT GenBank databases resulted in the identification
of 959 additional predicted B1BL genes, bringing the
total number predicted B1BL genes to 1199, correspond-
ing to 266 non-redundant sequences (Table 1). Clustering
using a sequence similarity cut-off of 70% showed that
these genes formed 71 families, 50 of which were previ-
ously uncharacterized.
Next, the search method was used to identify novel
B1BL genes in 5.7 terabases of short sequence reads
from metagenomes (Table 2). The metagenomic datasets
were selected to represent both the human microbiome
as well as bacterial communities from different environ-
ments. Special priority was given to metagenomes from
heavily polluted environments, which have previously
been shown to contain a high abundance and diversity
of resistance genes [13, 34, 35]. The relative abundance
of B1BL gene fragments ranged from 13.8 to 79.0 B1BL
fragments per million metagenomic fragments (Fig. 1).
The levels were significantly higher in the environmental
metagenomes compared to the human microbiome
Table 1 Summary of the analyzed genome datasets and predicted B1BL genes
Data set Size (nt) Sequences Predicted
B1BL genes
Familiesa Description
Known New
Bacteria 9.23 × 109 5.24 × 103 92 7 35 NCBI RefSeq bacteria [73]
Plasmid 5.22 × 108 9.23 × 103 148 7 1 NCBI RefSeq plasmid [73]
NT 5.22 × 1010 2.07 × 107 944 21 36 NCBI NT [74]
EnvNT 9.55 × 109 2.07 × 107 15 1 13 NCBI environmental NT [74]
Total 7.19 × 1010 4.15 × 107 266b 21b 50b
aBased on a sequence similarity cut-off of 70%
bNon-redundant genes
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(p = 0.0167, Wilcoxon rank sum test). The highest abun-
dance of B1BL gene fragments was found in the river
sediment sampled close to and from Hospital effluent in
Pune, India (“Pune river”). Assembly of the fragments
from the metagenomic data search resulted in the
identification of 16 full-length genes (Table 2). Among
these genes, 13 were classified as new B1BL gene fam-
ilies while three were previously characterized (NDM-1,
IMP-37, and EBR-1).
In total, the analysis of the genomic and metagenomic
data resulted in the identification of 279 unique B1BL
genes, of which 76 were novel. Of these novel genes, 21
were selected for experimental verification (Table 3).
Each gene was synthesized, transformed into an E.
coli host, and then the imipenem hydrolyzing activity
was assessed using the Carba NP test. In total, 18 of
the 21 selected genes (86%) were able to hydrolyze
imipenem, while three genes (G24, G65, and G69) did
not show any enzymatic activity (Table 3). In
addition, the P. stutzeri DSM 10701 strain, which was
predicted to contain a novel B1BL gene, yielded a
positive Carba NP test.
The 76 predicted and previously uncharacterized B1BL
genes clustered into 59 novel families (Additional file 2:
Table S1), resulting in a total of 81 B1BL families
described to date. The protein lengths of the families
ranged from 236 aa (G58 and EBR-1) to 278 aa (G01),
with an average of 251 aa. The sequence identity
between the families, old and new, ranged from 20.35 up
to 66.67%. After combining the previously characterized
B1BL gene families with a representative sequence from
each novel family predicted in this study, phylogenetic
analysis revealed five larger groups, denoted here as
B1–1 to B1–5 (Fig. 2).
The first two groups, B1–1 and B1–2, contained 17
novel B1BL families together with many of the mobile
B1BLs, including NDM, FIM, VIM, KHM, IMP, SIM,
GIM, DIM, and TMB [3, 36]. The previously charac-
terized, chromosomally encoded B1BL families ALI,
SLB, SFB, and ERL were also present in these groups.
All identified bacterial hosts of the chromosomal
genes in these two groups belonged to the phylum
Proteobacteria. While the hosts of the B1–1 group all
belonged to the Alpha- and Deltaproteobacteria, the
identified hosts of the B1–2 group all belonged to the
taxonomic class Gammaproteobacteria, with the genus
Shewanella accounting for 67% of the genes.
Table 2 Summary of the analyzed metagenomes and predicted B1BL genes
Data set Size (nt) Reads Predicted
B1BL genes
Familiesa Description
Known New
Isakavagu river 3.89 × 1010 3.85 × 108 0 0 0 Polluted river sediment [15]
Kazipally lake 6.75 × 109 6.68 × 107 0 0 0 Polluted lake [13]
Patancheru soil 4.73 × 1010 4.68 × 108 0 0 0 Soil [62]
Patancheru well 7.32 × 1010 7.25 × 108 3 0 3 Well water [62]
WWTP 4.82 × 1011 5.18 × 109 8 2 6 Sewage treatment plants [14]
Oil spill 2.75 × 1011 2.72 × 109 1 0 1 Oil spill [61]
Pune river 3.91 × 1011 3.11 × 109 4 1 3 River water [63]
Human gut 1 3.71 × 1011 5.22 × 109 0 0 0 Human gut [59]
Human gut 2 2.74 × 1011 3.41 × 109 0 0 0 Human gut [60]
HMP 4.69 × 1012 4.41 × 1010 0 0 0 Human microbiome [53]
Total 5.65 × 1012 6.54 × 1010 16 3 13
aBased on a sequence similarity cut-off of 70%
Fig. 1 The relative abundance of B1BL gene fragments in the analyzed
metagenomic data. The relative abundance of B1BL gene fragments
varied between 13.8 and 79.0 per million metagenomic fragments.
There was a significant difference in abundance between the
environmental metagenomes (left) and the human microbiome (right)
(p = 0.0167, Wilcoxon rank sum test). The highest levels were observed
in the river sediments sampled close to the effluent of a hospital in
Pune, India (“Pune river”)
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The third group (B1–3) consisted of 25 novel B1BL
families and one previously characterized B1BL family
(CcrA). All bacterial hosts of the chromosomal genes in
this group, both the representative genes and the
members of the families, belonged to the phylum
Bacteroidetes. Two of the families in this group
consisted of genes located in pathogens, where G29 in
family 22 was found on the chromosome of an isolate
from the poultry pathogen Ornithobacterium rhinotra-
cheale [37] and G04 in family 4 was present on a
plasmid harbored by an isolate of the opportunistic
pathogen Myroides odoratimimus [38].
The B1–4 group was formed from 13 novel families
and seven previously known chromosomal genes, in-
cluding BcII, EBR, IND, TUS, BlaB, JOHN, and PEDO3
[21, 39]. Among the 13 novel families, six were identified
from environmental sequence data (EnvNT and environ-
mental metagenomes). The hosts carrying chromosomal
genes were from the Bacteroidetes and Firmicutes phyla.
The fifth group (B1–5) was the smallest and consisted
of only four B1BL families, of which three were novel
and one was known (the plasmid-mediated SPM-1).
Interestingly, two of the predicted genes (G09 in family
9 and G76 in family 59) had an atypical zinc-binding
motif in which the residue H116, present in previously
reported B1BL genes [27], was replaced with a glycine.
One of these genes, G09, was confirmed to have
imipenem-hydrolyzing activity when expressed in E. coli.
These two genes were the only sequences in this analysis
where the zinc-binding motif differed.
Discussion
This study substantially extends our knowledge of the
diversity within the B1 subclass of metallo-β-lactamases.
By exploring 2906 bacterial genomes, 9230 plasmid
sequences and more than 5 terabases of metagenomic
data, we predicted 76 previously uncharacterized B1BL
genes with less than 70% amino acid identity to previ-
ously known metallo-β-lactamases. These genes were
divided into 59 novel families, revealing that the diver-
sity within the B1BL subclass of metallo-β-lactamases is
far greater than what has previously been described.
Experimental validation of 21 selected genes showed that
18 (86%) were able to hydrolyze imipenem when
expressed in an E. coli host. This provides strong confi-
dence to the applied computational method. In addition,
the predicted enzymatic activity was also confirmed for
the gene present in the strain P. stutzeri DSM 10701.
Table 3 Summary of the 22 experimentally verified B1BL genes
Source data set Gene ID Predicted family Group Proposed name Protein length (aa) Positive Carba NP test
RefSeq plasmid G04 4 B1–3 MYO-1 266 Yes
RefSeq bacteria G06 6 B1–2 SHD-1 265 Yes
RefSeq bacteria G09 9 B1–5 SPS-1 263 Yes
RefSeq bacteria G12 11 B1–1 MYX-1 262 Yes
RefSeq bacteria G13 12 B1–1 STA-1 262 Yes
RefSeq bacteria G24 17 B1–3 259 No
RefSeq bacteria G27 20 B1–1 ANA-1 258 Yes
RefSeq bacteria G28 21 B1–3 ECV-1 258 Yes
RefSeq bacteria G29 22 B1–3 ORR-1 256 Yes
RefSeq bacteria G31 24 B1–4 FIA-1 254 Yes
WWTP G33 25 B1–3 252 Yes
WWTP G37 29 B1–4 251 Yes
RefSeq bacteria G52 36 B1–3 ZOG-1 247 Yes
Patancheru well G58 41 B1–4 245 Yes
RefSeq bacteria G63 46 B1–2 TTU-1 244 Yes
Pune river G65 48 B1–3 242 No
RefSeq bacteria G67 50 B1–2 PST-1 243 Yesa
RefSeq bacteria G69 52 B1–3 242 No
Patancheru well G70 53 B1–2 242 Yes
Oil spill G71 54 B1–2 240 Yes
RefSeq bacteria G74 57 B1–2 SHN-1 238 Yes
RefSeq bacteria G77 ALI B1–2 ALI-2 246 Yes
aStrain tested
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Fig. 2 (See legend on next page.)
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The phylogenetic analysis revealed that all but one (G38,
family 30) of the novel B1BL genes identified in this
study, together with the previously known B1BL genes,
could be divided into five main groups, which could be
largely explained by the taxonomic affiliation of their
corresponding hosts. Proteobacteria, which were repre-
sented by two large groups in the phylogenetic tree,
dominated, followed by Bacteroidetes. All mobile B1BL
families, except for SPM, were located in the two
Proteobacteria-associated groups, indicating that the
clinically important mobile B1BL genes originated in
Proteobacteria and that, in the future, the host range for
mobile B1BL genes acquired by pathogens may be lim-
ited. Interestingly, Bacteroidetes was found to be highly
overrepresented in relation to the number of genomes
present in the databases, suggesting that they more fre-
quently carry B1BLs. Furthermore, we also found that
B1BLs were significantly overrepresented among Gram-
negative bacteria compared to Gram-positive. However,
we did not find any overrepresentation of B1BL in
pathogens or human-associated bacteria. These results
substantially increase the number of gene families of
subclass B1 [39] and provides a more detailed view of
the evolutionary history of this important subclass of
metallo-β-lactamases.
The genetic contexts of two of the novel B1BL genes
suggest that they may be mobile. First, the B1BL gene
G67 (family 50) (in this study named PST-1), found on
the chromosome of P. stutzeri DSM 10701, phylogenet-
ically clustered with the previously characterized mobile
B1BL families KHM, SIM, and IMP. The gene was lo-
cated on a structurally variable region that was absent in
the five other P. stutzeri strains present in the RefSeq
database. In addition, no homology could be found with
other species within the Pseudomonas genus, and no
known integrons or transposons could be detected in
the up- or downstream regions of the gene. There was,
however, weak homology to two other genes located on
the same insert as the predicted β-lactamase. These
genes, NERD and Fic, have previously been found on
plasmids, phages, and associated with integrons and
have been suggested to code for mechanisms related to
the horizontal transfer of genetic material [30, 40].
Pseudomonas is notorious for carrying mobile class B β-
lactamases [41, 42], and several of the known mobile
B1BL families were initially identified in this genus (IMP,
VIM, SPM, and GIM) [43]. Thus, our results indicate
that the production of PST-1 by P. stutzeri DSM 10701
may be the result of a recent gene acquisition event and
that this gene could therefore, potentially, be a member
of a previously uncharacterized mobile B1BL family.
Second, the gene G04 (in this study named MYO-1) in
family 4 was located, together with a tetracycline resist-
ance gene, on a plasmid in the genome of the opportun-
istic pathogen M. odoratimimus strain PR63039. This
gene phylogenetically belonged to group B1–3, along
with the chromosomal Bacteroidetes BLB1 genes, and
was the only mobile gene in this cluster. Furthermore,
the plasmid also contained parts of a class B conjugation
system, which is known to be predominantly found in
the Bacteroidetes phylum [33]. Thus, our results suggest
that this gene was potentially mobilized from a species
within the Bacteroidetes phylum and that its host-range
may be limited at present. However, when validated in E.
coli, the gene showed enzymatic activity despite no
codon optimization, demonstrating that it is functional
in a Proteobacterial host. Gene transfer events between
Bacteroidetes and Gram-positive bacteria have been pre-
viously suggested to occur [44], and therefore, it cannot
be excluded that this gene may be, or become, transfer-
able to pathogens outside Bacteroidetes. This gene may
thus constitute an important factor to be considered for
clinically relevant carbapenem resistance in the future.
The remaining B1BL genes predicted in this study did
not have any clear indications regarding their mobility
with respect to their genetic context or their location in
the phylogenetic tree. However, the majority of the
tested B1BLs exhibited enzymatic activity in E. coli.
Thus, if these genes were to become mobilized and
spread to pathogenic bacteria, they may constitute a
threat to human health in the future [45]. Furthermore,
the large increase in known chromosomal B1BL genes
will enable more detailed phylogenetic studies of the B1
subclass of metallo-β-lactamases [23], an essential step
to further elucidate the evolution and origins of mobile
B1BL genes.
The phylogenetic analysis showed that 9 out of the 10
known mobile B1BL gene families clustered together
with chromosomal B1BL genes in Proteobacteria (groups
B1–1 and B1–2; the only exception was SPM-1). Inter-
estingly, the B1–2 group, which contained 6 of the
known mobile B1BLs, was highly overrepresented by
(See figure on previous page.)
Fig. 2 A phylogenetic tree describing the evolutionary relationship between the B1 metallo-β-lactamases predicted in this study. The tree was
created from representative sequences for the gene families generated by clustering of predicted and previously characterized B1BL at a 70%
amino sequence identity cutoff (see “Methods” section). Previously characterized B1BL genes are annotated with the gene name. Novel gene
families that were predicted in this study are annotated with the corresponding family number and the sources (metagenome or species name
of the host). The numbers in parenthesis indicate how many unique genes there are in each family. The tree was divided into 5 groups
(B1–1 to B1–5) as referred to in the text. Complete information on the predicted genes and families are available in Additional file 2: Table S1
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chromosomal genes from the Shewanella genus.
Shewanella has previously been hypothesized to be the
origin of mobile antibiotic resistance genes, including
the class D carbapenemase OXA-48 (Shewanella onei-
densis, [46]) and the fluoroquinolone resistance gene
qnrA (Shewanella algae [47]). Thus, our results suggest
that many of the known mobile B1BL genes likely origi-
nated from hosts associated with the phylum Proteobac-
teria, especially Shewanella spp. In addition, our results
suggest that clinically relevant mobile B1BL genes ori-
ginating from hosts outside Proteobacteria are rare. This
could potentially be due to the many barriers preventing
genes from being efficiently transferred between phyla.
The beta-lactamase protein needs to be transported out-
side the cytoplasmic membrane of the cell to induce a
resistance phenotype, and its signal peptides therefore
need to be recognized by the host [48, 49]. β-Lactamases
also need to be highly expressed to provide high levels
of resistance, which requires a codon distribution that is
suitable for the host cell [50]. In fact, all of the predicted
genes that showed negative Carba NP tests were located
in the Bacteroidetes group B1–3, and two of them con-
tained codons that are rare in E. coli. Since the experi-
mental validation was based on the identified protein
sequences and no codon optimization was applied, rare
codons could potentially explain the lack of observed
enzymatic activity. Another explanation could be that
their signal peptides were not recognized by E. coli.
Thus, it is plausible that many B1BL genes from distant
phyla may be less suitable for Proteobacterial hosts and
may therefore not yield any substantial resistance pheno-
type. Furthermore, many forms of conjugative elements,
which are the primary mechanisms for the transfer of
antibiotic resistance genes between cells, have a limited
host range that can prevent sharing of genes between
phylogenetically distant species [51, 52]. Indeed, the
identified bacterial hosts carrying the mobile B1BLs IMP
and VIM all belong to the phylum Proteobacteria.
Nevertheless, our validation showed that 6 of 8 (75%) of
the chromosomally located genes from phyla other than
Proteobacteria were able to hydrolyze imipenem in an E.
coli host, suggesting that no further evolution is needed
for them to be functional should they be horizontally
transferred. This suggests that, at least in theory, the re-
cruitment of B1BL genes outside of Proteobacteria
should be possible. It should, however, be pointed out
that such genes may pose a significant risk if present in,
or transferred to, pathogens belonging to their original
phylum. Furthermore, we noted that none of the known
mobile B1BL genes had a close match to a chromosomal
gene in a known pathogenic or non-pathogenic bacterial
species. This suggests that the known mobile B1BL
genes either were not recently mobilized or originated
from species with yet uncharacterized genomes. Given
that a large proportion of the pathogenic- and human-
associated bacteria have been sequenced to date [53], it
is plausible that many of the mobile B1BL genes have an
environmental origin. Nevertheless, our results underscore
the fact that Proteobacteria, in particular Shewanella,
constitutes an important reservoir for the mobilization of
B1BLs.
In B1 enzymes, the Zn(II) ion at the first binding site
is coordinated to the residues His116, His118, and
His196, according to the standard BBL numbering
scheme [27], while the second binding site for the sec-
ond Zn(II) ion is coordinated by the residues Asp120,
Cys221, and His263. Interestingly, two of the novel
B1BL genes, G09 (here named SPS-1, in family 9) and
G76 (in family 59), which were both located in the fifth
group (B1–5), had the conserved His116 replaced by a
glycine, which has previously not been reported in any
class B β-lactamase. One of these enzymes was selected
for validation (SPS-1 in family 9; see Table 3 and
Additional file 2: Table S1), and its imipenem hydrolyz-
ing activity was confirmed when expressed in E. coli.
Metallo-β-lactamases in the closely related B2 subclass
are known to have the His116 replaced by asparagine
[3]. Mutational analysis of the subclass B2 gene CphA
has shown that the replacement of asparagine with histi-
dine at position His116 resulted in a 12- and 260-fold
increase in activity against penicillins and cephalospo-
rins, respectively [54]. Thus, it cannot be excluded that
the changes in the zinc-binding sites of SPS-1 and G76,
and potentially other yet to be described β-lactamases
within this group, may have significantly different en-
zymatic activities and substrate spectra. It should be
noted that, based on the current paradigm of three
separate B subclasses (B1, B2, and B3), our study clearly
classified SPS-1 and G76 as B1 β-lactamases. Thus, our
results suggest that the B1 subclass has a higher diversity
of zinc-binding sites than what has previously been
described in the literature.
Thirteen of the predicted B1BL genes were identified
from metagenomic data, all of which were assembled
from environmental samples, primarily polluted ones.
The abundance of B1BL gene fragments was also found
to be three-fold higher in the environmental metagenomes
compared to metagenomes from the human microbiome,
although the variation between the environmental meta-
genomes was high. This further strengthens the hypoth-
eses that the environment serves as an unexplored
reservoir of class B β-lactamases, which is in agreement
with previous studies [11, 20]. However, there were B1BL
fragments found in the human microbiome, especially in
stool samples, but no assembly of full-length genes was
possible. To investigate if this was due to lack of sequen-
cing depth, we attempted to pool the B1BL gene frag-
ments from different individuals based on body site, but
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no significant improvement was observed. One likely rea-
son for the inability to identify new B1BLs in the human-
associated metagenomes is the combination of the low
abundance of β-lactam resistance genes with the high di-
versity of the microbiome, both between individuals and
body sites [53]. In contrast to the environmental metagen-
omes, where replicated samples were taken from similar,
often spatially close, communities, the human-associated
data used in this study were comprised of samples from a
large number of individuals, each sequenced at a limited
depth. Thus, deeper sequencing of the individual samples
is likely necessary to identify potential variants only
present in smaller proportions of individuals. However,
our results indicate that many of the identified fragments
are false positives and that there is likely no single
widespread previously uncharacterized B1BL gene in the
human microbiomes investigated.
The identification of novel β-lactamases was based on
a probabilistic profile hidden Markov model (HMM)
designed to identify novel B1BL gene families. Compared
to more standard bioinformatics approaches to hom-
ology searches, such as BLAST, profile HMMs take the
position-specific sequence conservation into account
and therefore offer much higher sensitivity [55]. The
model was optimized using cross-validation where the
probability to identify a B1BL gene excluded from the
model was maximized. This enabled us to identify novel
B1BL genes, even in highly fragmented sequence data,
with high accuracy. This is underscored by the experi-
mental validation where imipenem hydrolysis was
verified in 86% (18 of 21 tested genes) of the validated
genes. In addition, two of the genes that showed no ac-
tivity both contained several codons that are considered
rare in E. coli, suggesting that they may not have been
translated with sufficient efficiency and could be func-
tional in other hosts. Taken together, it is therefore likely
that the majority of the genes predicted in this study
that were not subjected to validation are also novel,
functional B1BLs.
Conclusions
Computational analysis of more than 10,000 sequences
from genomes, plasmids, and > 5 terabases of metage-
nomic data was used to identify novel B1BLs. In total,
59 novel families containing 76 novel B1BL genes were
predicted, and 86% of the validated genes showed imipe-
nem hydrolyzing activity when expressed in E. coli. Two
of the predicted genes were located in genetic contexts
that suggest they may be horizontally transferable. Our
analysis showed that the B1BL genes can be organized
into five separate phylogenetic groups and that the ma-
jority of all known mobile B1BL genes were found to be
closely related to chromosomal genes of the Shewanella
genus and other Proteobacterial species. Furthermore,
two identified novel B1BL genes had an atypical zinc-
binding motif in their active site that has not previously
been described within class B metallo-β-lactamases. This
study substantially expands the number of described
B1BLs and identifies genes that, if mobilized into patho-
gens, could pose a threat to our ability to efficiently treat
multidrug-resistant bacteria. Our results also provide a
more detailed picture of the diversity and evolutionary
history of B1BLs.
Methods
Description of the computational method
The novel B1 metallo-β-lactamase (B1BL) genes identi-
fied in this study were predicted using a computational
method based on a hidden Markov model (HMM). The
method was designed to take either whole genomes or
metagenomes as input and provide the predicted full-
length genes as an output. A flowchart summarizing the
method is provided in Additional file 1: Figure S1. For
complete genomes, the method searched for matches
against the HMM, which were classified as B1BL de-
pending on the score. For metagenomes, the method
first performed a quality control of the reads, then
searched each fragment using the HMM. Fragments
classified as being derived from a B1BL gene were then
assembled and elongated (if the assembled gene was not
of full-length).
The HMM used to identify evolutionary conserved
patterns from B1BL genes was built from a training
dataset consisting of representative sequences from 20
verified genes in the B1 metallo-β-lactamase subclass
(Additional file 3: Table S2). The corresponding protein
sequences were downloaded from the NCBI database
(http://www.ncbi.nlm.nih.gov/) during September of
2015. The training sequences were aligned with Clus-
talW using the default settings [56] and then were used
as input (“training dataset”) for the HMM. The model
was built using HMMER version 3.1b1 [57] using
“hmmbuild” with the default settings.
Optimization of the probabilistic model
The score cut-off of the model was optimized to identify
novel families in genome sequences using leave-one-out
cross-validation. First, a model was built from the train-
ing dataset with one gene excluded. The excluded gene
was then subjected to the model and the true positive
rate, defined as the proportion of correctly identified se-
quences at a specific score, was estimated. This process
was repeated 20 times, one time for each gene in the
training dataset. To estimate the specificity of the model,
we assembled a “false” dataset consisting of 38 selected
genes from the closest known homologs, the 17 groups
of the MBL superfamily [58], which were downloaded
from UniProt (http://www.uniprot.org/) and from the
Berglund et al. Microbiome  (2017) 5:134 Page 9 of 13
NCBI FTP site (ftp://ftp.ncbi.nlm.nih.gov/) during
September of 2015. The false positive rate of the model
was estimated based on the incorrectly classified genes.
The ratio between the true and false positive rate was
used to determine an optimal threshold score for a gene
to be classified as B1BL.
To optimize the threshold score for the model when
applied to metagenomic data, the cross-validation was
additionally performed for gene fragments. The excluded
B1 gene was randomly cut into 10,000 fragments, each
100 nucleotides long, corresponding to the most com-
mon read length for Illumina sequence data, and then
was analyzed by the model. The true positive rate was
then calculated as the proportion of correctly classified
fragments. The false positive rate was estimated by both
(1) fragmented genes from the MBL superfamily (as
described above) and (2) fragments randomly selected
from 1000 bacterial genomes (from NCBI RefSeq), from
which every predicted MBL subclass B1 gene had been
removed.
Based on the results of the cross-validation, the score
threshold for the full-length genes was set to 135.4,
corresponding to a true positive rate of 100% and a false
positive rate of 0% for the MBL superfamily. For
fragmented data, the score was set to 10, corresponding
to a true positive rate of 89% and a false positive rate of
4 and 0% for the MBL superfamily and random genomic
fragments, respectively (Additional file 4: Figure S2).
Processing genomic and metagenomic data
Genomes and plasmids from the NCBI datasets (RefSeq
Bacteria, RefSeq Plasmid, NT and Environmental NT)
were downloaded from the NCBI FTP site (ftp://
ftp.ncbi.nlm.nih.gov/) during the spring of 2015, except
for the NCBI RefSeq plasmids, which were downloaded
in the spring of 2016. The metagenomic datasets
(Additional file 5: Table S3) consisted of raw Illumina se-
quence reads from the human gut microbiome (“Human
gut 1” [59], “Human gut 2” [60]), and the human micro-
biome (“HMP” [53]). In addition, datasets from various
polluted environments were included and consisted of
oil-exposed marine sediments (“oil spill” [61]), a
pharmaceutical-polluted lake (“polluted lake” [13]),
Swedish waste water treatment plants (“WWTP” [14]),
and pharmaceutical-polluted river sediments (“Isakavagu
river” [15]). We also included samples from bacterial
communities in soil and well water (“Patancheru soil,”
“Patancheru well” [62]) and from river sediments in
Pune (“Pune river,” [63]).
The metagenomic data were processed as follows: data
in FASTQ format was quality controlled using the FASTX-
toolkit version 0.13.2 [64] with “fastq_quality_filter,” in
which sequences containing ambiguous bases were re-
moved. The sequences were then converted to FASTA
with “fastq_to_fasta.” After conversion, the sequences were
translated into amino acid sequences in all six reading
frames using EMBOSS “transeq” version 6.3.1 [65] with
the parameters “-frame 6 -table 11.” All amino acid se-
quences were analyzed with HMMER3 using “hmmsearch”
with parameters “–domtblout -E 1000 –domE 1000” using
the HMM described above. The domain score, envelope
start (env_start), envelope end (env_end), and sequence ID
were extracted from the output of hmmsearch and were
classified as a B1BL if the domain score was higher than
the previously calculated score threshold.
For the metagenomic data, the fragments matching
the HMM were assembled with CAP3 [66] using a strict
identity cutoff of 97% and a minimal overlap of 30 nu-
cleotides with the options “-p 97 -o 30.” If the assembled
potential B1 gene was not full-length, it was extended as
follows: first, the reads in the quality-filtered FASTA files
were mapped to the contig using USEARCH [67] with
the options “-usearch_local -strand both -id 0.7 -blast6-
out.” The fragments matching the contig template were
collected together with their corresponding paired-end
read and then assembled using SPAdes [68] with the
options “–sc –only-assembler.” If the contig was too
short to contain a full-length B1BL gene, the procedure
was repeated up to three times.
All putative B1BL genes that were assembled from
metagenomic data were subjected to an additional
quality control. This was done by mapping reads from
the samples from which they were identified back to the
contigs with Bowtie2 [69] using the parameters “-x
<templateContig.fa> -1 <retrievedReads1.fq> -2 <retrie-
vedReads2.fq.” The physical coverage, defined as the
number of spanning paired-end reads, was then calcu-
lated for each position. Contigs where the physical
coverage was zero at any nucleotide position were
excluded from the analysis. Finally, the full-length genes
were analyzed by the model again, and genes with a
score of less than the threshold for full-length genes
were discarded.
Experimental validation
To assess the functionality of the predicted novel genes,
21 of the candidate novel genes (ORFs) were synthesized
at ThermoFisher Scientific, Germany, using the GeneArt
gene synthesis service. The genes were subcloned into
the expression vector pZE21-MCS1 [70]. The recombin-
ant pZE21-MCS1 plasmids containing the novel resist-
ance gene candidates were then transformed into E. coli
C600Z1 (Expressys Ruelzheim, Germany) by electropor-
ation. The expression of the cloned gene was induced
using anhydroteteracycline (aTc). To assess imipenem
hydrolysis, Carba NP tests were carried out on overnight
cultures grown on Mueller Hilton agar plates containing
100 ng/ml of aTc [71]. Imipenem was procured from
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Glentham Life Sciences, UK. An E. coli C600Z1 strains
carrying the pZE21-MCS1 vector with a synthesized
NDM-1 gene insert or no insert were used as positive
and a negative controls, respectively. Additionally, Kleb-
siella pneumoniae CCUG 64452 (OXA-48), K. pneumo-
niae CCUG 56233 (KPC-2), and K. pneumoniae CCUG
58547 (VIM-2) were used as positive controls; and En-
terobacter cloacae CCUG 59627 (AmpC combined with
decreased porin expression), K. pneumoniae CCUG
59359 (TEM-52), and E. coli CCUG 17620 (an antibiotic
sensitive type strain) were used as negative controls for
the Carba NP test.
Phylogenetic analysis
Phylogenetic analysis was performed to summarize the
results and to visualize the evolutionary relationships
between the predicted B1BL genes. First, redundant
genes were removed by clustering the sequences with a
100% sequence identity cut-off using USEARCH with
the parameters “-cluster-fast <retrieved-sequences.fasta>
-id 1 –centroids <unique-genes.fasta> -sort length –uc
<cluster-file.uc>.” The set of representative genes for
each cluster (the centroids) was then spiked with the
previously confirmed genes from the B1, B2, and B3 sub-
classes, respectively. Glyoxalase II (NP_973679.1) from
the MBL superfamily was used as an outgroup [58]. The
genes were divided into gene families by clustering at a
70% amino sequence identity cut-off using USEARCH
with the parameters: “-cluster_fast <fasta-file> -id 0.7 –
centroids <centroids.out> -sort length –uc cluster.ou-
t.uc.” Clusters that did not contain any previously
experimentally confirmed B1BL genes were annotated as
novel gene families. A phylogenetic tree was created
based on this set of centroid genes using ETE NPR [72]
with the parameters “-a < centroid_file > −w standard_-
fasttree.” The predicted genes and families were all given a
consecutive identifier abbreviated as “GXX” and “family
Y.” Furthermore, predicted genes that were experimentally
confirmed to hydrolyze imipenem were named according
to current nomenclature. Finally, the genetic context of
the selected genes was annotated using NCBI GenBank,
ResFinder, and CONJscan-T4SSscan.
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